Anti-TNF antibodies, compositions, methods and uses
Details for Australian Patent Application No. 2001279227 (hide)
International Classifications
Event Publications
20 September 2007 Application Accepted
Published as AU-B-2001279227
17 January 2008 Standard Patent Sealed
10 June 2010 Extension of Term of Standard Patents
Centocor, Inc The earliest first regulatory approval date provided by the patentee 13 Nov 2013 For the goods SIMPONI golimumab
5 August 2010 Extension of Term of Standard Patents
Centocor, Inc The earliest first regulatory approval date provided by the patentee 13 Nov 2013 For the goods SIMPONI golimumab Address for service in Australia: Shelston IP Level 21 60 Margaret Street Sydney NSW 2000
27 January 2011 Extension granted
Centocor, Inc The earliest first regulatory approval date provided by the patentee 13 Nov 2009 For the goods SIMPONI golimumab Extension of Term of patent pursuant to Section 77 expires on 13 Nov 2024
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser